474 related articles for article (PubMed ID: 34335591)
1. Thrombosis in Psoriasis: Cutaneous Cytokine Production as a Potential Driving Force of Haemostatic Dysregulation and Subsequent Cardiovascular Risk.
Visser MJE; Tarr G; Pretorius E
Front Immunol; 2021; 12():688861. PubMed ID: 34335591
[TBL] [Abstract][Full Text] [Related]
2. Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in Psoriasis: A Prospective Cohort Study.
Goyal A; Dey AK; Chaturvedi A; Elnabawi YA; Aberra TM; Chung JH; Belur AD; Groenendyk JW; Lerman JB; Rivers JP; Rodante JA; Harrington CL; Varghese NJ; Sanda GE; Baumer Y; Sorokin AV; Teague HL; Genovese LD; Natarajan B; Joshi AA; Playford MP; Bluemke DA; Chen MY; Alavi A; Pitman RK; Powell-Wiley TM; Tawakol A; Gelfand JM; Mehta NN
JACC Cardiovasc Imaging; 2020 Feb; 13(2 Pt 1):465-477. PubMed ID: 30448131
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammation, cardiometabolic diseases and effects of treatment: Psoriasis as a human model.
Aksentijevich M; Lateef SS; Anzenberg P; Dey AK; Mehta NN
Trends Cardiovasc Med; 2020 Nov; 30(8):472-478. PubMed ID: 31837960
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis.
Lockshin B; Balagula Y; Merola JF
J Am Acad Dermatol; 2018 Aug; 79(2):345-352. PubMed ID: 29477740
[TBL] [Abstract][Full Text] [Related]
5. Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment.
Guttman-Yassky E; Krueger JG; Lebwohl MG
Exp Dermatol; 2018 Apr; 27(4):409-417. PubMed ID: 28266782
[TBL] [Abstract][Full Text] [Related]
6. New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis.
Karczewski J; Dobrowolska A; Rychlewska-Hańczewska A; Adamski Z
Autoimmunity; 2016 Nov; 49(7):435-450. PubMed ID: 27050731
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation: a promoter for psoriasis and its comorbidity, cardiovascular disease.
Jiang Z; Jiang X; Chen A; He W
Front Immunol; 2023; 14():1238647. PubMed ID: 37654493
[TBL] [Abstract][Full Text] [Related]
8. TNF-α inhibitors reduce the pathological Th
Campanati A; Orciani M; Lazzarini R; Ganzetti G; Consales V; Sorgentoni G; Di Primio R; Offidani A
Exp Dermatol; 2017 Apr; 26(4):319-324. PubMed ID: 27376466
[TBL] [Abstract][Full Text] [Related]
9. The Role of Helper T Cells in Psoriasis.
Hu P; Wang M; Gao H; Zheng A; Li J; Mu D; Tong J
Front Immunol; 2021; 12():788940. PubMed ID: 34975883
[TBL] [Abstract][Full Text] [Related]
10. T Helper Cell Subsets in Clinical Manifestations of Psoriasis.
Diani M; Altomare G; Reali E
J Immunol Res; 2016; 2016():7692024. PubMed ID: 27595115
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation on effector T cells in the pathogenesis of psoriasis.
Qu Y; Li D; Xiong H; Shi D
Eur J Med Res; 2023 Jun; 28(1):182. PubMed ID: 37270497
[TBL] [Abstract][Full Text] [Related]
12. Altered distribution of leukocyte subsets and cytokine production in response to acute psychosocial stress in patients with psoriasis vulgaris.
Buske-Kirschbaum A; Kern S; Ebrecht M; Hellhammer DH
Brain Behav Immun; 2007 Jan; 21(1):92-9. PubMed ID: 16714097
[TBL] [Abstract][Full Text] [Related]
13. Double trouble: psoriasis and cardiometabolic disorders.
Mahyoodeen NG; Crowther NJ; Tikly M
Cardiovasc J Afr; 2018 May/Jun 23; 29(3):189-194. PubMed ID: 29293257
[TBL] [Abstract][Full Text] [Related]
14. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.
Vollmer S; Menssen A; Trommler P; Schendel D; Prinz JC
Eur J Immunol; 1994 Oct; 24(10):2377-82. PubMed ID: 7925564
[TBL] [Abstract][Full Text] [Related]
15. Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case report.
Fan JM; Solomon DA; López GY; Hofmann JW; Colorado RA; Kim AS; Meisel K; Halabi C
BMC Neurol; 2020 Mar; 20(1):106. PubMed ID: 32199449
[TBL] [Abstract][Full Text] [Related]
16. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.
Novelli L; Chimenti MS; Chiricozzi A; Perricone R
Autoimmun Rev; 2014 Jan; 13(1):64-9. PubMed ID: 24021172
[TBL] [Abstract][Full Text] [Related]
17. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
[TBL] [Abstract][Full Text] [Related]
18. A pathogenetic approach to autoimmune skin disease therapy: psoriasis and biological drugs, unresolved issues, and future directions.
Ayroldi E; Bastianelli A; Cannarile L; Petrillo MG; Delfino DV; Fierabracci A
Curr Pharm Des; 2011; 17(29):3176-90. PubMed ID: 21864268
[TBL] [Abstract][Full Text] [Related]
19. TPA induction leads to a Th17-like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis.
Hvid H; Teige I; Kvist PH; Svensson L; Kemp K
Int Immunol; 2008 Aug; 20(8):1097-106. PubMed ID: 18579711
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic and pharmacological assessment of murine IL-23 mediated psoriasiform dermatitis; implications for drug discovery.
Gauld SB; Gauvin D; Olson L; Leys L; Paulsboe S; Liu Z; Edelmayer RM; Wetter J; Salte K; Wang Y; Huang S; Honore P; McGaraughty S
J Dermatol Sci; 2018 Oct; 92(1):45-53. PubMed ID: 30149967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
